Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
- PMID: 33657286
- DOI: 10.1056/NEJMc2100217
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Comment in
-
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. Reply.N Engl J Med. 2021 Apr 15;384(15):1473-1474. doi: 10.1056/NEJMc2100217. Epub 2021 Mar 3. N Engl J Med. 2021. PMID: 33657287 No abstract available.
-
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. Reply.N Engl J Med. 2021 Apr 15;384(15):1474. doi: 10.1056/NEJMc2100217. Epub 2021 Mar 3. N Engl J Med. 2021. PMID: 33657288 No abstract available.
Comment on
-
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.N Engl J Med. 2020 Dec 10;383(24):2333-2344. doi: 10.1056/NEJMoa2028836. Epub 2020 Oct 21. N Engl J Med. 2020. PMID: 33085857 Free PMC article. Clinical Trial.
-
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.N Engl J Med. 2021 Jan 7;384(1):20-30. doi: 10.1056/NEJMoa2030340. Epub 2020 Dec 17. N Engl J Med. 2021. PMID: 33332779 Free PMC article. Clinical Trial.
Similar articles
-
Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection.Respir Care. 2022 May;67(5):629-630. doi: 10.4187/respcare.10067. Respir Care. 2022. PMID: 35473844 No abstract available.
-
Tocilizumab in patients hospitalized with COVID-19 pneumonia: systematic review and meta-analysis of randomized controlled trials.J Investig Med. 2022 Jan;70(1):55-60. doi: 10.1136/jim-2021-002001. Epub 2021 Sep 24. J Investig Med. 2022. PMID: 34561232 Free PMC article.
-
Testing the efficacy of tocilizumab in patients with COVID-19 pneumonia.J Comp Eff Res. 2021 Jun;10(8):625-627. doi: 10.2217/cer-2021-0050. Epub 2021 Apr 23. J Comp Eff Res. 2021. PMID: 33887951 Free PMC article. No abstract available.
-
Benign SARS-CoV-2 infection in MOG-antibodies associated disorder during tocilizumab treatment.Mult Scler Relat Disord. 2020 Nov;46:102592. doi: 10.1016/j.msard.2020.102592. Epub 2020 Oct 21. Mult Scler Relat Disord. 2020. PMID: 33296987 Free PMC article.
-
The effect of tocilizumab on severe COVID-19 infection: Review of current evidence.Tuberk Toraks. 2021 Mar;69(1):74-83. doi: 10.5578/tt.20219909. Tuberk Toraks. 2021. PMID: 33853308 Review. English.
Cited by
-
The immunological response among COVID-19 patients with acute respiratory distress syndrome.J Infect Public Health. 2021 Jul;14(7):954-959. doi: 10.1016/j.jiph.2021.05.007. Epub 2021 May 26. J Infect Public Health. 2021. PMID: 34130119 Free PMC article. Review.
-
Making Drug Approval Decisions in the Face of Uncertainty: Cumulative Evidence versus Value of Information.Med Decis Making. 2024 Jul;44(5):512-528. doi: 10.1177/0272989X241255047. Epub 2024 Jun 3. Med Decis Making. 2024. PMID: 38828516 Free PMC article.
-
Ivermectin as a potential treatment for COVID-19?PLoS Negl Trop Dis. 2021 Jun 1;15(6):e0009446. doi: 10.1371/journal.pntd.0009446. eCollection 2021 Jun. PLoS Negl Trop Dis. 2021. PMID: 34061842 Free PMC article. No abstract available.
-
Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19?Int J Mol Sci. 2021 May 26;22(11):5672. doi: 10.3390/ijms22115672. Int J Mol Sci. 2021. PMID: 34073529 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources